Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.8857
-0.0343 (-3.73%)
At close: Mar 9, 2026, 4:00 PM EDT
0.8857
0.00 (0.00%)
After-hours: Mar 9, 2026, 5:31 PM EDT

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had revenue of $820.19K in the quarter ending December 31, 2025, a decrease of -26.22%. This brings the company's revenue in the last twelve months to $4.51M, down -6.73% year-over-year. In the fiscal year ending June 30, 2025, InMed Pharmaceuticals had annual revenue of $4.94M with 7.50% growth.

Revenue (ttm)
$4.51M
Revenue Growth
-6.73%
P/S Ratio
0.77
Revenue / Employee
$346,661
Employees
13
Market Cap
3.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20254.94M344.90K7.50%
Jun 30, 20244.60M462.17K11.18%
Jun 30, 20234.14M3.05M279.61%
Jun 30, 20221.09M--
Jun 30, 2021---
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IM Cannabis37.61M
Sunshine Biopharma37.32M
cbdMD19.09M
Sonoma Pharmaceuticals17.72M
RedHill Biopharma9.55M
China Pharma Holdings4.05M
China SXT Pharmaceuticals1.54M
Akanda836.66K
Revenue Rankings

INM News

More News